Abstract
Purpose
Methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionReferences
- A school-hospital and university-based adolescent pregnancy prevention program.J Reprod Med. 1984; 29: 421-426
- Oral contraceptive for the adolescent.J Reprod Med. 1984; 29: 551-559
- Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.Contraception. 2006; 73: 594-597
- Medical eligibility criteria for contraceptive use. Reproductive health and research.3rd ed. WHO, Geneva2004
- Cigarette smoking, menstrual symptoms and miscarriage among young women.Aust N Z J Public Health. 2000; 24: 413-420
- Chapman & Hall, London (England)1991: 250 Practical statistics for medical research.
- Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.Contraception. 2000; 61: 309-316
- Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.Contraception. 1999; 60: 87-92
- Multicentred, Phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5mg as a monthly injectable contraceptive; final three-year report.Contraception. 1994; 50: 329-337
- Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.Contraception. 1989; 39: 619-632
Article info
Publication history
Footnotes
���Financial support: the injections were provided, free of charge, by Schering Brasil (Schering, Berlin, Germany) to the Family Planning Clinic. No other funding was received, from Schering or any other industry or agency, in support of this research. There was no conflict of interest by any of the authors.